erlotinib hydrochloride has been researched along with Cytomegalovirus Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, CK; Lee, CN; Po-Chao Chiu, F | 1 |
1 other study(ies) available for erlotinib hydrochloride and Cytomegalovirus Infections
| Article | Year |
|---|---|
Cutaneous cytomegalovirus (CMV) infection in a patient with metastasized lung cancer.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Cytomegalovirus Infections; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male | 2021 |